Your browser doesn't support javascript.
loading
A study in a rat initiation-promotion bladder tumour model demonstrated no promoter/progressor potential of dapagliflozin.
Billger, Martin; Kirk, Jason; Chang, Jane; Bédard, Agathe; Attalla, Bassem; Haile, Solomon; Söderberg, Magnus.
Afiliación
  • Billger M; Drug Safety and Metabolism, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden. Electronic address: Martin.Billger@astrazeneca.com.
  • Kirk J; Drug Safety and Metabolism, IMED Biotech Unit, AstraZeneca, Cambridge, UK. Electronic address: Jason.Kirk@astrazeneca.com.
  • Chang J; Drug Safety and Metabolism, IMED Biotech Unit, AstraZeneca, Waltham, MA, USA. Electronic address: Jane.Chang1@astrazeneca.com.
  • Bédard A; Charles River Laboratories, Montreal, Canada. Electronic address: Agathe.Bedard@crl.com.
  • Attalla B; Charles River Laboratories, Montreal, Canada. Electronic address: bazatala@gmail.com.
  • Haile S; Charles River Laboratories, Montreal, Canada. Electronic address: solomon.haile@crl.com.
  • Söderberg M; Drug Safety and Metabolism, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden. Electronic address: Magnus.Soderberg@astrazeneca.com.
Regul Toxicol Pharmacol ; 103: 166-173, 2019 Apr.
Article en En | MEDLINE | ID: mdl-30685222
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Compuestos de Bencidrilo / Neoplasias de la Vejiga Urinaria / Modelos Animales de Enfermedad / Glucósidos Límite: Animals Idioma: En Revista: Regul Toxicol Pharmacol Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Compuestos de Bencidrilo / Neoplasias de la Vejiga Urinaria / Modelos Animales de Enfermedad / Glucósidos Límite: Animals Idioma: En Revista: Regul Toxicol Pharmacol Año: 2019 Tipo del documento: Article